Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Searcey

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug News & Perspectives|February 9, 2010
Optimizing drugs for local deliveryS Collingwood, R Lock, M Searcey
The Biochemical Journal|June 15, 1992
Polyclonal antibody-catalysed amide hydrolysisG Gallacher, M Searcey, C S Jackson, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Bifunctional alkylating agents derived from duocarmycin SA: potent antitumor activity with altered sequence selectivityD L Boger, M Searcey, W C Tse, et al.
Anti-Cancer Drug Design|September 29, 1999
Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustardsS McClean, C Costelloe, W A Denny, et al.
Anti-Cancer Drug Design|May 21, 1999
Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivativesM Searcey, S McClean, B Madden, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Antitumour antibiotics with potent activity against multidrug resistant (MDR) Staphylococcus aureus: a new approach to targeting resistant bacteriaM A Casely-Hayford, N Ortuzar Kerr, E Smith, et al.
European Journal of Biochemistry|May 15, 1993
Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition stateG Gallacher, C S Jackson, M Searcey, et al.
The Journal of Organic Chemistry|June 24, 2000
Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysisD L Boger, A Santillán, M Searcey, et al.
Biochemical Society Transactions|August 1, 1990
Polyclonal-antibody-catalysed hydrolysis of an aryl nitrophenyl carbonateG Gallacher, C S Jackson, C M Topham, et al.
The Biochemical Journal|November 1, 1991
A polyclonal antibody preparation with Michaelian catalytic propertiesG Gallacher, C S Jackson, M Searcey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug News & Perspectives|February 9, 2010
Optimizing drugs for local deliveryS Collingwood, R Lock, M Searcey
The Biochemical Journal|June 15, 1992
Polyclonal antibody-catalysed amide hydrolysisG Gallacher, M Searcey, C S Jackson, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Bifunctional alkylating agents derived from duocarmycin SA: potent antitumor activity with altered sequence selectivityD L Boger, M Searcey, W C Tse, et al.
Anti-Cancer Drug Design|September 29, 1999
Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustardsS McClean, C Costelloe, W A Denny, et al.
Anti-Cancer Drug Design|May 21, 1999
Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivativesM Searcey, S McClean, B Madden, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Antitumour antibiotics with potent activity against multidrug resistant (MDR) Staphylococcus aureus: a new approach to targeting resistant bacteriaM A Casely-Hayford, N Ortuzar Kerr, E Smith, et al.
European Journal of Biochemistry|May 15, 1993
Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition stateG Gallacher, C S Jackson, M Searcey, et al.
The Journal of Organic Chemistry|June 24, 2000
Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysisD L Boger, A Santillán, M Searcey, et al.
Biochemical Society Transactions|August 1, 1990
Polyclonal-antibody-catalysed hydrolysis of an aryl nitrophenyl carbonateG Gallacher, C S Jackson, C M Topham, et al.
The Biochemical Journal|November 1, 1991
A polyclonal antibody preparation with Michaelian catalytic propertiesG Gallacher, C S Jackson, M Searcey, et al.
Pageof 1